R P Schneider - JoVE Visualize

Showing results (31-40 of 44) with videos related to

Pageof 5

Sort By:

Analytical Chemistry|September 1, 1991

Electrospray ionization mass spectrometry of semduramicin and other polyether ionophoresR P Schneider, M J Lynch, J F Ericson, et al.

Helvetica Chirurgica Acta|June 1, 1989

[Conservative treatment of splenic injuries in the adult]R P Schneider, V Merz, R Meuli, et al.

Applied and Environmental Microbiology|April 1, 1996

Homology between genes for aromatic hydrocarbon degradation in surface and deep-subsurface Sphingomonas strainsE Kim, P J Aversano, M F Romine, et al.

Journal of Veterinary Pharmacology and Therapeutics|July 6, 2007

The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil modelV de la Puente-Redondo, F D Tingley, R P Schneider, et al.

Journal of Veterinary Pharmacology and Therapeutics|July 6, 2007

The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogsH A Benchaoui, S R Cox, R P Schneider, et al.

Journal - Association of Official Analytical Chemists|July 1, 1991

Determination of carbadox-related residues in swine liver by gas chromatography/mass spectrometry with ion trap detectionM J Lynch, F R Mosher, R P Schneider, et al.

Experimental Eye Research|October 21, 1998

An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse modelB A Cowell, M D Willcox, J A Hobden, et al.

Journal of Bacteriology|August 1, 1995

Physical mapping and characterization of a catabolic plasmid from the deep-subsurface bacterium Sphingomonas sp. strain F199L C Stillwell, S J Thurston, R P Schneider, et al.

CPT: Pharmacometrics & Systems Pharmacology|September 19, 2024

Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II dataStefan Willmann, Adam Lloyd, Rupert Austin, et al.

CPT: Pharmacometrics & Systems Pharmacology|May 30, 2021

Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessmentRebekka Fendt, Ute Hofmann, Annika R P Schneider, et al.

Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:

Pageof 5

Analytical Chemistry|September 1, 1991

Electrospray ionization mass spectrometry of semduramicin and other polyether ionophoresR P Schneider, M J Lynch, J F Ericson, et al.

Helvetica Chirurgica Acta|June 1, 1989

[Conservative treatment of splenic injuries in the adult]R P Schneider, V Merz, R Meuli, et al.

Applied and Environmental Microbiology|April 1, 1996

Homology between genes for aromatic hydrocarbon degradation in surface and deep-subsurface Sphingomonas strainsE Kim, P J Aversano, M F Romine, et al.

Journal of Veterinary Pharmacology and Therapeutics|July 6, 2007

The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil modelV de la Puente-Redondo, F D Tingley, R P Schneider, et al.

Journal of Veterinary Pharmacology and Therapeutics|July 6, 2007

The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogsH A Benchaoui, S R Cox, R P Schneider, et al.

Journal - Association of Official Analytical Chemists|July 1, 1991

Determination of carbadox-related residues in swine liver by gas chromatography/mass spectrometry with ion trap detectionM J Lynch, F R Mosher, R P Schneider, et al.

Experimental Eye Research|October 21, 1998

An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse modelB A Cowell, M D Willcox, J A Hobden, et al.

Journal of Bacteriology|August 1, 1995

Physical mapping and characterization of a catabolic plasmid from the deep-subsurface bacterium Sphingomonas sp. strain F199L C Stillwell, S J Thurston, R P Schneider, et al.

CPT: Pharmacometrics & Systems Pharmacology|September 19, 2024

Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II dataStefan Willmann, Adam Lloyd, Rupert Austin, et al.

CPT: Pharmacometrics & Systems Pharmacology|May 30, 2021

Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessmentRebekka Fendt, Ute Hofmann, Annika R P Schneider, et al.

Pageof 5